Gelesis Holdings, Inc. (GLSHQ)
USD 0.0
(-79.0%)
USD 0.0
(-79.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 117.74 Million USD | 39.27% |
| 2021 | 86.17 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 10.6 Million USD | -15.1% |
| 2023 Q1 | 12.49 Million USD | -15.77% |
| 2022 FY | 120.01 Million USD | 39.27% |
| 2022 Q4 | 14.82 Million USD | -29.26% |
| 2022 Q3 | 20.96 Million USD | -45.6% |
| 2022 Q2 | 38.53 Million USD | -15.64% |
| 2022 Q1 | 45.68 Million USD | 121.47% |
| 2021 Q1 | 16.88 Million USD | 0.0% |
| 2021 Q3 | 28.53 Million USD | 41.73% |
| 2021 Q2 | 20.13 Million USD | 19.2% |
| 2021 FY | 86.17 Million USD | 0.0% |
| 2021 Q4 | 20.62 Million USD | -27.7% |
| 2020 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -8717.228% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -2235.323% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -298.43% |
| Nascent Biotech, Inc. | 2.22 Million USD | -5180.466% |
| Rebus Holdings, Inc. | 664 Thousand USD | -17633.133% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -216.054% |
| Qrons Inc. | 643.67 Thousand USD | -18193.026% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -30125.43% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -104.993% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -28240.301% |
| Skye Bioscience, Inc. | 13.54 Million USD | -769.146% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | -35.678% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -2294.268% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -44889.034% |
| SQZ Biotechnologies Company | 85.61 Million USD | -37.526% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -3937.672% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -7739.941% |
| Mesoblast Limited | 5.9 Million USD | -1895.053% |
| Marizyme, Inc. | 19.23 Million USD | -512.001% |
| Genus plc | 147.7 Million USD | 20.279% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -1241.21% |
| Pharming Group N.V. | 225.49 Million USD | 47.782% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -5647.436% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -8677.044% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -1312.016% |
| ContraFect Corporation | 56.88 Million USD | -106.979% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -2570.827% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -7862.66% |
| IMV Inc. | 37.7 Million USD | -212.253% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -4119.818% |
| MultiCell Technologies, Inc. | 567.42 USD | -20751371.573% |
| ONE Bio Corp. | 6.44 Million USD | -1727.281% |
| Accustem Sciences Inc. | 3.74 Million USD | -3042.948% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -37.004% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -22034.664% |
| Q BioMed Inc. | 3.43 Million USD | -3326.266% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -376.423% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -4381.333% |
| Biomind Labs Inc. | 994.18 Thousand USD | -11743.707% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | -18.542% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -6591.452% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -1652.72% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -6215.699% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 471092.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -635.454% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -6316.453% |
| GB Sciences, Inc. | 1.42 Million USD | -8189.141% |
| Alpha Cognition Inc. | 9.7 Million USD | -1113.196% |
| HST Global, Inc. | 140.9 Thousand USD | -83464.337% |
| CSL Limited | 3.44 Billion USD | 96.586% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -10367.326% |
| Halberd Corporation | 74.84 Thousand USD | -157228.773% |
| Enzolytics Inc. | 2.17 Million USD | -5302.506% |
| Agentix Corp. | 1.37 Million USD | -8483.742% |
| Resverlogix Corp. | 12.71 Million USD | -826.274% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -3125.348% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 92.322% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -11178.544% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -4796.101% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -7355.449% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -3358.112% |
| AVAX Technologies, Inc. | 7.31 Million USD | -1510.722% |
| Zenith Capital Corp. | 8.94 Million USD | -1216.65% |
| Genscript Biotech Corporation | 825.34 Million USD | 85.733% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -675796.906% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -4695.633% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -68554.123% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -6029.816% |
| Kadimastem Ltd | 2.41 Million USD | -4785.582% |
| Helix BioMedix, Inc. | 1.97 Million USD | -5870.891% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -983.537% |
| BioStem Technologies, Inc. | 22.97 Million USD | -412.509% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -64780.293% |
| LadRx Corporation | 3.81 Million USD | -2989.047% |
| Cell Source, Inc. | 4.32 Million USD | -2622.279% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -12650.051% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -12650.051% |
| NovAccess Global Inc. | 2.46 Million USD | -4673.385% |
| Affymax, Inc. | 39.38 Million USD | -198.959% |
| Itoco Inc. | 919.14 Thousand USD | -12710.629% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -2678.115% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -10422.609% |
| Mobile Lads Corp. | 554.54 Thousand USD | -21133.225% |
| CytoDyn Inc. | 18.05 Million USD | -552.054% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -467729.473% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -53402.849% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -8193.327% |
| SYBLEU INC | 160.87 Thousand USD | -73091.775% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -6382.778% |
| International Stem Cell Corporation | 5.27 Million USD | -2133.884% |
| Bioxytran, Inc. | 3.82 Million USD | -2982.29% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -223576.912% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -578713.351% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -224.679% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -7177.379% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -15901.957% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -3684.892% |
| Neutra Corp. | 243.82 Thousand USD | -48192.805% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -574.503% |
| PureTech Health plc | 144.59 Million USD | 18.568% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -474.664% |
| IXICO plc | 4.7 Million USD | -2401.551% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -1238.502% |
| CSL Limited | 3.89 Billion USD | 96.975% |
| Cellectis S.A. | 97.32 Million USD | -20.991% |